惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

V
V2EX
宝玉的分享
宝玉的分享
Jina AI
Jina AI
IT之家
IT之家
博客园 - Franky
MyScale Blog
MyScale Blog
Y
Y Combinator Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
I
InfoQ
雷峰网
雷峰网
WordPress大学
WordPress大学
Microsoft Security Blog
Microsoft Security Blog
Google DeepMind News
Google DeepMind News
美团技术团队
S
SegmentFault 最新的问题
罗磊的独立博客
博客园 - 聂微东
大猫的无限游戏
大猫的无限游戏
H
Help Net Security
D
Docker
博客园 - 司徒正美
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
阮一峰的网络日志
阮一峰的网络日志
M
MIT News - Artificial intelligence

Latest News Today, Breaking News, Current News | The HinduBusinessLine

India’s critical mineral import dependence rises as demand surges: NITI Aayog NCLT stays approval of Subhash Chandra’s ₹6.25-crore repayment plan CDSCO to significantly step up audits, inspections of medical-device makers: DCGI Ethanol Cartel: ‘Revolving Door Policy’ in Adjudication diminish CCI Again 'Utterly horrified and shocked' by the attack on Rushdie: Tharoor IPCC report warns India on emissions, says indigenous knowledge key to save crops from drought Wealth of India's 10 richest enough to fund school, higher education of every child for 25 years: Study Instagram, WhatsApp and Facebook restored after global outage Instagram, WhatsApp and Facebook face outage Greenhouse gas emissions linked to national dietary guidelines: Study Zoom’s revenue up 326% in FY2021 1 in 4 may suffer from hearing loss by 2050: WHO report WHO panel advises against use of hydroxychloroquine for COVID-19 Public attitude more “infectious” than COVID-19 Nasscom, Microsoft announce pact to accelerate AI-led Innovation in India Shipping Corporation records 52-week high on stake sale Reliance Retail raises Rs 5,512.5 crore from GIC Lockdowns meant to slow down infection rate, not eliminate virus: Anand Mahindra US to allow Air India to conduct ground handling at airports Unlock 4.0: Metros can resume operations from Sep 7 in a graded manner, says Home Ministry Covid-19: India under complete lockdown for next 21 days starting midnight, says PM Modi
Haffkine Institute gets Centre’s nod to manufacture Covaxin
By Our Bureau · 2021-04-16 · via Latest News Today, Breaking News, Current News | The HinduBusinessLine

This will be done with the transfer of technology from Bharat Biotech

Updated - April 16, 2021 at 10:04 AM.

| Pune

  CHENNAI, TAMIL NADU, 17/01/2021 :   Covaxin  Vaccine immunisation for Covid-19 at Rajiv Gandhi Govt.General Hospital on Sunday. Photo:  Ragu R / The Hindu

CHENNAI, TAMIL NADU, 17/01/2021 : Covaxin Vaccine immunisation for Covid-19 at Rajiv Gandhi Govt.General Hospital on Sunday. Photo: Ragu R / The Hindu | Photo Credit: RAGU R

The central government has given permission to the Haffkine Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech.

“ The central government’s Science and Technology Department has given permission to manufacture Covaxin with the transfer of technology from Bharat Biotech. Chief Minister Uddhav Thackeray has thanked Prime Minister Narendra Modi for accepting his request and issuing the permission” CM Office tweeted at 11.27 pm on Thursday.

The Dept of Science & Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri @narendramodi for approving this request.

— CMO Maharashtra (@CMOMaharashtra) April 15, 2021
 

In March, Thackeray had urged the Centre to grant permission to State-owned Haffkine to manufacture Covid-19 vaccine. Thackeray had told PM that Haffkine can manufacture Covid -19 vaccine after technology transfer under Mission Covid-19 and under the guidance of the ICMR. Or it can also work under fill and finish basis. In case of any option, it can produce 126 million doses, Thackeray had said.

The press statement by the CM office added that in a letter to Maharashtra Chief Secretary Sitaram Kunte, Department of Science and Technology Secretary Renu Swaroop, informed that the approval was given as per the recommendation of the committee of scientific experts and a period of one year has been given for the development of Covaxin.

Haffkine Bio-Pharmaceutical Corporation should start production as soon as possible in view of the current growing infection and demand for vaccines, the letter said. The institute should appoint experienced and trained technicians, it added.

“ CM Thackeray has also asked the Chief Secretary to appoint a senior officer to monitor the project and complete the production on time” the press note added.

Published on April 15, 2021